Titre:
  • Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
Auteur:Gallant, Joel J.E.; Ward, Doug; Morales-Ramirez, Javier; Yan, Mingjin; Abram, Michael M.E.; Plummer, Andrew; Cheng, Andrew K; Rhee, Martin M.S.; Daar, Eric E.S.; Raffi, François; Brinson, Cynthia; Ruane, Peter; Dejesus, Edwin; Johnson, Margaret; Clumeck, Nathan; Osiyemi, Olayemi
Informations sur la publication:The lancet. HIV, 3, 4, page (e158-e165)
Statut de publication:Publié, 2016-04
Sujet CREF:Généralités
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2352-3018
info:doi/10.1016/S2352-3018(16)00024-2
info:pii/S2352301816000242
info:scp/84960824872